A case of atypical hemolytic uremic syndrome due to anti-factor H antibody in a patient presenting with a factor XII deficiency identified two novel mutations

Clinical and Experimental Nephrology

Volumn 15, Issue 2, 2011, Pages 269-274

  Matsukuma, Eiji ^a,b,c   Gotoh, Yoshimitsu ^b   Kuroyanagi, Yoshiyuki ^b   Yamada, Takuji ^b   Iwasa, Mitsuji ^b   Yamakawa, Satoshi ^d   Nagai, Takuhito ^d   Takagi, Nobuaki ^e   Mae, Hiromu ^e   Iijima, Kenji ^f   Bresin, Elena ^g  

^a GIFU PREFECTURAL GIFU HOSPITAL   (Japan)

^b NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^c GIFU UNIVERSITY   (Japan)

^d AICHI CHILDREN'S HEALTH AND MEDICAL CENTER   (Japan)

^e HYOGO COLLEGE OF MEDICINE   (Japan)

^f TOTTORI UNIVERSITY   (Japan)

^g MARIO NEGRI INST PHARMACOL RES   (Italy)

Author keywords

Anti factor H antibody; Atypical hemolytic uremic syndrome; Coagulation factor XII deficiency; Factor H; Prolonged APTT

Indexed keywords

COMPLEMENT FACTOR H; COMPLEMENT FACTOR H ANTIBODY; HEMOGLOBIN; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; UNCLASSIFIED DRUG;

ARTICLE; BIOPSY; BLOOD CLOTTING FACTOR 12 DEFICIENCY; BLOOD TRANSFUSION; CASE REPORT; CELL PROLIFERATION; CELL SWELLING; CHILD; CLINICAL FEATURE; FEVER; GENE EXPRESSION; GENE MUTATION; HEMATURIA; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HEMOLYTIC ANEMIA; HEMOLYTIC UREMIC SYNDROME; HETEROZYGOSITY; HUMAN; INFLUENZA A; KIDNEY FAILURE; MALE; PALLOR; PARTIAL THROMBOPLASTIN TIME; PHYSICAL EXAMINATION; PLASMAPHERESIS; PROTEINURIA; RECURRENT DISEASE; RETICULOCYTE COUNT; SCHOOL CHILD; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT RESPONSE; URINALYSIS;

AUTOANTIBODIES; CHILD; COMPLEMENT FACTOR H; FACTOR XII; FACTOR XII DEFICIENCY; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MALE; MUTATION; PARTIAL THROMBOPLASTIN TIME; RENAL DIALYSIS;

EID: 79959236862     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-010-0375-z     Document Type: Article

References (18)

1. Dragon-Durey MA, Fremeaux-Bacchi V. Atypical haemolytic uraemic syndrome and mutations in complement regulator genes. Semin Immunopathol. 2005;27:359-74. (Pubitemid 41639887)
2. Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med. 2009;361:1676-87.
3. Atkinson J, Liszewski M, Richards A, Kavanagh D, Moulton EA. Hemolytic uremic syndrome. An example of insufficient complement regulation on self tissue. Ann N Y Acad Sci. 2005;1056:144-52.
4. Warwicker P, Goodship TH, Donne RL, Pirson Y, Nicholls A, Ward RM, et al. Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int. 1998;4:1085-6.
5. Dragon-Durey MA, Loirat C, Cloarec S, Macher MA, Blouin J, Nivet H, et al. Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2005;16:555-63. (Pubitemid 41725154)
6. Jozsi M, Strobel S, Dahse HM, Liu WS, Hoyer PF, Oppermann M, et al. Anti-factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome. Blood. 2007;111:1512-4.
7. Kluft C, Dooijewaard G, Emeis JJ. Role of the contact system in fibrinolysis. Semin Thromb Hemost. 1987;13:50-68. (Pubitemid 17034603)
8. Saito H. Contact factors in health and disease. Semin Thromb Hemost. 1987;13:36-49. (Pubitemid 17034602)
9. Halbmayer WM, Haushofer A, Schön R, Mannhalter C, Strohmer E, Baumgarten K, et al. The prevalence of moderate and severe FXII (Hageman factor) deficiency among the normal population: evaluation of the incidence of FXII deficiency among 300 healthy blood donors. Thromb Haemost. 1994;71:68-72. (Pubitemid 24023789)
10. Kanaji T, Kanaji S, Osaki K, Kuroiwa M, Sakaguchi M, Mihara K, et al. Identification and characterization of two novel mutations (Q421K and R123P) in congenital factor XII deficiency. Thromb Haemost. 2001;86:1409-15. (Pubitemid 34007512)
11. Moake JL. Thrombotic microangiopathies. N Eng J Med. 2002; 347:589-600.
12. Allford SL. Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. Br J Haematol. 2003;120:556-73.
13. Kwon T, Dragon-Durey MA, Macher MA, Baudouin V, Maisin A, Peuchmaur M, et al. Successful pre-transplant management of a patient with anti-factor H autoantibodies-associated haemolytic uraemic syndrome. Nephrol Dial Transplant. 2008;23:2088-90. (Pubitemid 351768178)
14. Zeerleder S, Schloesser M, Redondo M, Wuillemin WA, Engel W, Furlan M, et al. Reevaluation of the incidence of thromboembolic complications in congenital factor XII deficiency - a study on 73 subjects from 14 Swiss families. Thromb Haemost. 1999;82:1240-6. (Pubitemid 29473785)
15. Pauer HU, Burfeind P, Köstering H, Emons G, Hinney B. Factor XII deficiency is strongly associated with primary recurrent abortions. Fertil Steril. 2003;80:590-4. (Pubitemid 37102871)
16. Goodnough LT, Saito H, Ratnoff OD. Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: a report of 21 patients and a review of 50 previously reported cases. Medicine. 1983;62:248-55. (Pubitemid 13037004)
17. DiScipio RG. The activation of the alternative pathway C3 convertase by human plasma kallikrein. Immunology. 1982;45: 587-95. (Pubitemid 12165625)
18. Schmaier AH. The elusive physiologic role of Factor XII. J Clin Invest. 2008;118:3006-9.